Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.
Charity organisation Sickle Cell Society has described the recommendation as a “major breakthrough” for sickle cell patients.
Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...
Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.